General FairJourney Bio delivers antibody engineering for novel tumor-conditional IL-12 therapeutic approach that unlocks the potential of localized cytokine activationBy Healthcare Propulsion StaffAugust 20, 20260 FairJourney Bio (“FJBio”), a global antibody discovery expert, today announced the publication of a peer-reviewed study in mAbs describing a…
